Nucleai
Anna Pokorska-Bocci is a highly experienced professional in the field of personalized medicine, currently serving as Principal Scientist at Debiopharm since February 2014. With a progressive career at Debiopharm, Anna has held titles including Associate Principal Scientist and Senior Scientific Officer. Prior to this, Anna's experience includes positions at PHG Foundation, where roles ranged from Programme Associate to Programme Lead, and a Project Coordinator role at the same foundation. Anna's early career includes significant experience as a Senior Scientist at Pharmagene/Asterand and as a Scientist at BioFocus Discovery Ltd.
This person is not in the org chart
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.